MONROVIA, Calif., Dec. 1 /PRNewswire-FirstCall/ -- STAAR Surgical Company , a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will present at the Harris Nesbitt Focus on Healthcare 2005 Conference at the Millennium Broadway Hotel in New York on Thursday, December 8, 2005. The Company is scheduled to discuss its business strategy and historical financial performance at 2:00 p.m. Eastern Time.
Attendance at the conference is by invitation only. A live audio-only webcast of STAAR’s presentation may be accessed through the Company’s website at www.staar.com. An archived replay of the presentation will be available for 6 months following the conference; this archive webcast will also be available through www.staar.com.
About STAAR Surgical
STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR’s products are used by ophthalmic surgeons and include the VISIAN ICL as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. STAAR’s ICL has received CE Marking, is approved for sale in 41 countries and has been implanted in more than 40,000 eyes worldwide. It is currently under review, but not yet approved, by the FDA for use in the United States.
CONTACT: Investors Media EVC Group EVC Group Douglas Sherk, 415-896-6820 Steve DiMattia, 646-277-8706 Jennifer Beugelmans, 415-896-6820
STAAR Surgical Company
CONTACT: investors, Douglas Sherk, +1-415-896-6820, or JenniferBeugelmans, +1-415-896-6820, or Steve DiMattia, +1-646-277-8706, all of EVCGroup, for STAAR Surgical
Web site: http://www.staar.com//
